BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20817702)

  • 1. Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancer.
    López-Encuentra A; López-Ríos F; Conde E; García-Luján R; Suárez-Gauthier A; Mañes N; Renedo G; Duque-Medina JL; García-Lagarto E; Rami-Porta R; González-Pont G; Astudillo-Pombo J; Maté-Sanz JL; Freixinet J; Romero-Saavedra T; Sánchez-Céspedes M; Gómez de la Camara A;
    Eur Respir J; 2011 Jan; 37(1):136-42. PubMed ID: 20817702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and evaluation of a prognostic prediction model for patients after complete resection of non-small cell lung cancer and multidisciplinary therapy].
    Wei WD; Fu JH; Lin P; Li XD; Yang H; Rong TH; Chen LK
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):672-5. PubMed ID: 19173908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
    Mandrekar SJ; Schild SE; Hillman SL; Allen KL; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Chansky K; Kelly K; Adjei AA; Jett JR
    Cancer; 2006 Aug; 107(4):781-92. PubMed ID: 16847887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
    Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
    Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.
    Oliaro A; Filosso PL; Cavallo A; Giobbe R; Mossetti C; Lyberis P; Cristofori RC; Ruffini E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):438-43; discussion 443. PubMed ID: 18502660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
    Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of non-small cell lung cancer (NSCLC): a review.
    Tsim S; O'Dowd CA; Milroy R; Davidson S
    Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter.
    Cangir AK; Kutlay H; Akal M; Güngör A; Ozdemir N; Akay H
    Lung Cancer; 2004 Dec; 46(3):325-31. PubMed ID: 15541817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of MAPK in non-small cell lung cancer].
    Zhang ZF; Ma JQ; Zhang L
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical tumour size and prognosis in lung cancer. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S).
    Eur Respir J; 1999 Oct; 14(4):812-6. PubMed ID: 10573226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification.
    León-Atance P; Moreno-Mata N; González-Aragoneses F; Cañizares-Carretero MÁ; García-Jiménez MD; Genovés-Crespo M; Honguero-Martínez AF; Rombolá CA; Simón-Adiego CM; Peñalver-Pascual R
    Arch Bronconeumol; 2011 Sep; 47(9):441-6. PubMed ID: 21676516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
    Gao YS; Xing XZ; Shao K; Feng XL; He J
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
    Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
    Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors.
    Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):963-7. PubMed ID: 20951601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.